NCT01167348 The Effectiveness Of Auricular Acupressure On Body Weight Parameters On Patients With Schizophrenia Status UNKNOWN Phase NA
NCT01164059 Clinical Effectiveness of Newer Antipsychotics in Comparison With Conventional Antipsychotics in Schizophrenia Status COMPLETED Phase PHASE4
NCT01161277 Effects of Aripiprazole and Haloperidol on Mesolimbic System Functioning Status COMPLETED Phase PHASE4
NCT01160991 Effect of Atypical Antipsychotic Drugs Olanzapine and Amisulpride on Glucose Metabolism Status COMPLETED Phase NA
NCT01160679 Effectiveness of Atypical Antipsychotics on Anhedonic Features in Patients With Schizophrenia Status COMPLETED Phase N/A
NCT01157351 15 Month Study for Adults Who Have Been Diagnosed With Schizophrenia and Incarcerated Status COMPLETED Phase PHASE4
NCT01154829 Pan European Collaboration on Antipsychotic Naive Schizophrenia (PECANS) Status COMPLETED Phase NA
NCT01150734 Neuromodulation in Depressed and Schizophrenic Patients - Changing MEP (Muscle Evoked Potentials) by tDCS (Transcranial Direct Current Stimulation) Status COMPLETED Phase N/A
NCT01150448 A Safety and Pharmacokinetic Study of Paliperidone Palmitate in Patients With Schizophrenia Status COMPLETED Phase PHASE1
NCT01149655 Efficacy & Safety Study of Oral Aripiprazole in Adolescents With Schizophrenia Status COMPLETED Phase PHASE3
NCT01149577 Effect of Olanzapine on Sleep Electroencephalogram (EEG) in Schizophrenia Patients Status COMPLETED Phase PHASE4
NCT01149551 CSP #572 - Genetics of Functional Disability in Schizophrenia and Bipolar Illness Status COMPLETED Phase N/A
NCT01143090 A Study of Subjects Switched to Lurasidone for the Treatment of Schizophrenia or Schizoaffective Disorder Status COMPLETED Phase PHASE3
NCT01143077 A Study Evaluating Lurasidone for The Treatment of Schizophrenia or Schizoaffective Disorder in Subjects Switched From Other Antipsychotic Agents Status COMPLETED Phase PHASE3
NCT01142596 Long-term Extension Trial of Asenapine in Subjects With Schizophrenia (Study P06125) Status COMPLETED Phase PHASE3